323 related articles for article (PubMed ID: 16461349)
1. Tumor necrosis factor-like weak inducer of apoptosis inhibits skeletal myogenesis through sustained activation of nuclear factor-kappaB and degradation of MyoD protein.
Dogra C; Changotra H; Mohan S; Kumar A
J Biol Chem; 2006 Apr; 281(15):10327-36. PubMed ID: 16461349
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor inducible 14 (Fn14) is required for the expression of myogenic regulatory factors and differentiation of myoblasts into myotubes. Evidence for TWEAK-independent functions of Fn14 during myogenesis.
Dogra C; Hall SL; Wedhas N; Linkhart TA; Kumar A
J Biol Chem; 2007 May; 282(20):15000-10. PubMed ID: 17383968
[TBL] [Abstract][Full Text] [Related]
3. TNF-like weak inducer of apoptosis (TWEAK) activates proinflammatory signaling pathways and gene expression through the activation of TGF-beta-activated kinase 1.
Kumar M; Makonchuk DY; Li H; Mittal A; Kumar A
J Immunol; 2009 Feb; 182(4):2439-48. PubMed ID: 19201899
[TBL] [Abstract][Full Text] [Related]
4. Cyclic mechanical strain inhibits skeletal myogenesis through activation of focal adhesion kinase, Rac-1 GTPase, and NF-kappaB transcription factor.
Kumar A; Murphy R; Robinson P; Wei L; Boriek AM
FASEB J; 2004 Oct; 18(13):1524-35. PubMed ID: 15466361
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of mechanosensitive cation channels inhibits myogenic differentiation by suppressing the expression of myogenic regulatory factors and caspase-3 activity.
Wedhas N; Klamut HJ; Dogra C; Srivastava AK; Mohan S; Kumar A
FASEB J; 2005 Dec; 19(14):1986-97. PubMed ID: 16319142
[TBL] [Abstract][Full Text] [Related]
6. S100B protein in myoblasts modulates myogenic differentiation via NF-kappaB-dependent inhibition of MyoD expression.
Tubaro C; Arcuri C; Giambanco I; Donato R
J Cell Physiol; 2010 Apr; 223(1):270-82. PubMed ID: 20069545
[TBL] [Abstract][Full Text] [Related]
7. Proinflammatory cytokine tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) suppresses satellite cell self-renewal through inversely modulating Notch and NF-κB signaling pathways.
Ogura Y; Mishra V; Hindi SM; Kuang S; Kumar A
J Biol Chem; 2013 Dec; 288(49):35159-69. PubMed ID: 24151074
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor-related weak inducer of apoptosis augments matrix metalloproteinase 9 (MMP-9) production in skeletal muscle through the activation of nuclear factor-kappaB-inducing kinase and p38 mitogen-activated protein kinase: a potential role of MMP-9 in myopathy.
Li H; Mittal A; Paul PK; Kumar M; Srivastava DS; Tyagi SC; Kumar A
J Biol Chem; 2009 Feb; 284(7):4439-50. PubMed ID: 19074147
[TBL] [Abstract][Full Text] [Related]
9. Lipopolysaccharide inhibits myogenic differentiation of C2C12 myoblasts through the Toll-like receptor 4-nuclear factor-κB signaling pathway and myoblast-derived tumor necrosis factor-α.
Ono Y; Sakamoto K
PLoS One; 2017; 12(7):e0182040. PubMed ID: 28742154
[TBL] [Abstract][Full Text] [Related]
10. TWEAK induces NF-kappaB2 p100 processing and long lasting NF-kappaB activation.
Saitoh T; Nakayama M; Nakano H; Yagita H; Yamamoto N; Yamaoka S
J Biol Chem; 2003 Sep; 278(38):36005-12. PubMed ID: 12840022
[TBL] [Abstract][Full Text] [Related]
11. Glutathione depletion impairs myogenic differentiation of murine skeletal muscle C2C12 cells through sustained NF-kappaB activation.
Ardite E; Barbera JA; Roca J; Fernández-Checa JC
Am J Pathol; 2004 Sep; 165(3):719-28. PubMed ID: 15331397
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization.
Langen RC; Van Der Velden JL; Schols AM; Kelders MC; Wouters EF; Janssen-Heininger YM
FASEB J; 2004 Feb; 18(2):227-37. PubMed ID: 14769817
[TBL] [Abstract][Full Text] [Related]
13. Myostatin inhibits myoblast differentiation by down-regulating MyoD expression.
Langley B; Thomas M; Bishop A; Sharma M; Gilmour S; Kambadur R
J Biol Chem; 2002 Dec; 277(51):49831-40. PubMed ID: 12244043
[TBL] [Abstract][Full Text] [Related]
14. The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression.
Tran NL; McDonough WS; Savitch BA; Sawyer TF; Winkles JA; Berens ME
J Biol Chem; 2005 Feb; 280(5):3483-92. PubMed ID: 15611130
[TBL] [Abstract][Full Text] [Related]
15. c-Src-dependent tyrosine phosphorylation of IKKbeta is involved in tumor necrosis factor-alpha-induced intercellular adhesion molecule-1 expression.
Huang WC; Chen JJ; Chen CC
J Biol Chem; 2003 Mar; 278(11):9944-52. PubMed ID: 12645577
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB.
Langen RC; Schols AM; Kelders MC; Wouters EF; Janssen-Heininger YM
FASEB J; 2001 May; 15(7):1169-80. PubMed ID: 11344085
[TBL] [Abstract][Full Text] [Related]
17. p38α MAPK disables KMT1A-mediated repression of myogenic differentiation program.
Chatterjee B; Wolff DW; Jothi M; Mal M; Mal AK
Skelet Muscle; 2016; 6():28. PubMed ID: 27551368
[TBL] [Abstract][Full Text] [Related]
18. TWEAK and cIAP1 regulate myoblast fusion through the noncanonical NF-κB signaling pathway.
Enwere EK; Holbrook J; Lejmi-Mrad R; Vineham J; Timusk K; Sivaraj B; Isaac M; Uehling D; Al-awar R; LaCasse E; Korneluk RG
Sci Signal; 2012 Oct; 5(246):ra75. PubMed ID: 23074266
[TBL] [Abstract][Full Text] [Related]
19. Genetic ablation of TWEAK augments regeneration and post-injury growth of skeletal muscle in mice.
Mittal A; Bhatnagar S; Kumar A; Paul PK; Kuang S; Kumar A
Am J Pathol; 2010 Oct; 177(4):1732-42. PubMed ID: 20724600
[TBL] [Abstract][Full Text] [Related]
20. Tumour necrosis factor-like weak inducer of apoptosis (TWEAK), an important mediator of endothelial inflammation, is associated with the pathogenesis of Henoch-Schonlein purpura.
Chen T; Guo ZP; Li MM; Li JY; Jiao XY; Zhang YH; Liu HJ
Clin Exp Immunol; 2011 Oct; 166(1):64-71. PubMed ID: 21762126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
